Schulman Rifka C, Moshier Erin L, Rho Lisa, Casey Martin F, Godbold James H, Mechanick Jeffrey I
Division of Endocrinology and Metabolism, Hofstra North Shore-LIJ School of Medicine, Long Island Jewish Medical Center, New Hyde Park, New York.
Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Endocr Pract. 2014 Sep;20(9):884-93. doi: 10.4158/EP13324.OR.
OBJECTIVE: Chronic critical illness (CCI) is a term used to designate patients requiring prolonged mechanical ventilation and tracheostomy with associated poor outcomes. The present study assessed the impact of glycemic parameters on outcomes in a CCI population. METHODS: A retrospective case series was performed including 148 patients in The Mount Sinai Hospital Respiratory Care Unit (2009-2010). Utilizing a semi-parametric mixture model, trajectories for the daily mean blood glucose (BG), BG range, and hypoglycemia rate over time identified low- (n = 87) and high-risk (n = 61) hyperglycemia groups and low- (n = 90) and high-risk (n = 58) hypoglycemia groups. The cohort was also classified into diabetes (DM, n = 48), stress hyperglycemia (SH, n = 85), and normal glucose (n = 15) groups. RESULTS: Hospital- (28% vs. 13%, P = .0199) and 1-year mortality (66% vs. 46%, P = .0185) rates were significantly greater in the high- versus low-risk hyperglycemia groups, respectively. The hypoglycemia rate (<70 mg/dL) was lower among ventilator-liberated patients compared to those who failed to liberate (0.092 vs. 0.130, P<.0001). In the SH group, both hospital mortality (high-risk hyperglycemia 48% and low-risk hyperglycemia 15%, P = .0013) and 1-year mortality (high-risk 74% and low-risk 50%, P = .0482) remained significantly different, while no significant difference in the diabetes group was observed. There were lower hypoglycemia rates with SH compared to diabetes (<70 mg/dL: 0.086 vs. 0.182, P<.0001; <40 mg/dL: 0.012 vs. 0.022, P = .0118, respectively). CONCLUSION: Tighter glycemic control was associated with improved outcomes in CCI patients with SH but not in CCI patients with diabetes. Confirmation of these findings may lead to stratified glycemic control protocols in CCI patients based on the presence or absence of diabetes.
目的:慢性危重病(CCI)是一个用于指代需要长期机械通气和气管切开且预后较差的患者的术语。本研究评估了血糖参数对CCI患者预后的影响。 方法:进行了一项回顾性病例系列研究,纳入了西奈山医院呼吸护理单元的148例患者(2009 - 2010年)。利用半参数混合模型,确定了每日平均血糖(BG)、血糖范围和低血糖发生率随时间的轨迹,将患者分为低风险(n = 87)和高风险(n = 61)高血糖组以及低风险(n = 90)和高风险(n = 58)低血糖组。该队列还被分为糖尿病(DM,n = 48)、应激性高血糖(SH,n = 85)和正常血糖(n = 15)组。 结果:高风险高血糖组的住院死亡率(28%对13%,P = 0.0199)和1年死亡率(66%对46%,P = 0.0185)分别显著高于低风险高血糖组。与未能脱机的患者相比,成功脱机的患者低血糖发生率更低(<70 mg/dL:0.092对0.130,P<0.0001)。在SH组中,住院死亡率(高风险高血糖组为48%,低风险高血糖组为15%,P = 0.0013)和1年死亡率(高风险组为74%,低风险组为50%,P = 0.0482)仍存在显著差异,而糖尿病组未观察到显著差异。与糖尿病组相比,SH组的低血糖发生率更低(<70 mg/dL:0.086对0.182,P<0.0001;<40 mg/dL:0.012对0.022,P = 0.0118)。 结论:更严格的血糖控制与SH型CCI患者预后改善相关,但与糖尿病型CCI患者无关。对这些发现的证实可能会导致基于糖尿病状态的CCI患者分层血糖控制方案。
Rev Diabet Stud. 2021-11-1
Support Care Cancer. 2018-12-15
Pediatr Crit Care Med. 2011-11
Int J Mol Sci. 2024-6-27
Mater Today Bio. 2022-12-1
Trends Endocrinol Metab. 2020-6
J Clin Med. 2019-7-7
Bioeng Transl Med. 2016-9
Nat Rev Drug Discov. 2014-11-28